Q1 2014

Filed Jun 2, 2014 · 10-Q · 63 days after period end · 0001583648-14-000007

Q1 2014 · 10-Q

Revenue

$1.37M

no prior Q1 2013 on file

Net Income

-$779.91K

no prior Q1 2013 on file

EPS Diluted

-$0.07

no prior Q1 2013 on file

Operating Income-$671,217—

Operating Cash Flow

Same quarter

no prior Q1 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2014 · filed Jun 2, 2014 · 63 d after period end

Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR